Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc

Molecular and Cellular Neuroscience

Volumn 38, Issue 1, 2008, Pages 98-109

  Aguib, Yasmine ^a   Gilch, Sabine ^a   Krammer, Carmen ^a   Ertmer, Alexa ^a   Groschup, Martin H ^b   Schätzl, Hermann M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; INFECTION SENSITIVITY; NERVE CELL; NEUROSECRETORY CELL; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL COMMUNICATION; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; INSULINOMA; MICE; NEUROSECRETORY SYSTEMS; PHEOCHROMOCYTOMA; PRION DISEASES; PRPC PROTEINS; PRPSC PROTEINS; SCRAPIE;

MURINAE;

EID: 43049142557     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2008.02.004     Document Type: Article

References (64)

1. Aguzzi A., and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 116 (2004) 313-327
2. Atouf F., Scharfmann R., Lasmezas C., and Czernichow P. Tight hormonal control of PrP gene expression in endocrine pancreatic cells. Biochem. Biophys. Res. Commun. 201 (1994) 1220-1226
3. Baker C.A., Martin D., and Manuelidis L. Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J. Virol. 76 (2002) 10905-10913
4. Baron G.S., Magalhaes A.C., Prado M.A., and Caughey B. Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. J. Virol. 80 (2006) 2106-2117
5. Bendheim P.E., Brown H.R., Rudelli R.D., Scala L.J., Goller N.L., Wen G.Y., Kascsak R.J., Cashman N.R., and Bolton D.C. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42 (1992) 149-156
6. Birkett C.R., Hennion R.M., Bembridge D.A., Clarke M.C., Chree A., Bruce M.E., and Bostock C.J. Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J. 20 (2001) 3351-3358
7. Borchelt D.R., Scott M., Taraboulos A., Stahl N., and Prusiner S.B. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J. Cell Biol. 110 (1990) 743-752
8. Bueler H., Aguzzi A., Sailer A., Greiner R.A., Autenried P., Aguet M., and Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 73 (1993) 1339-1347
9. Butler D.A., Scott M.R., Bockman J.M., Borchelt D.R., Taraboulos A., Hsiao K.K., Kingsbury D.T., and Prusiner S.B. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J. Virol. 62 (1988) 1558-1564
10. Cirulli V., Baetens D., Rutishauser U., Halban P.A., Orci L., and Rouiller D.G. Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation. J. Cell Sci. 107 (1994) 1429-1436
11. Come J.H., Fraser P.E., and Lansbury Jr. P.T. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 5959-5963
12. Daude N., Marella M., and Chabry J. Specific inhibition of pathological prion protein accumulation by small interfering RNAs. J. Cell Sci. 116 (2003) 2775-2779
13. Efrat S., Surana M., and Fleischer N. Glucose induces insulin gene transcription in a murine pancreatic beta-cell line. J. Biol. Chem. 266 (1991) 11141-11143
14. Enari M., Flechsig E., and Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9295-9299
15. Ertmer A., Gilch S., Yun S.W., Flechsig E., Klebl B., Stein-Gerlach M., Klein M.A., and Schatzl H.M. The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells. J. Biol. Chem. 279 (2004) 41918-41927
16. Farquhar C.F., Dornan J., Moore R.C., Somerville R.A., Tunstall A.M., and Hope J. Protease-resistant PrP deposition in brain and non-central nervous system tissues of a murine model of bovine spongiform encephalopathy. J. Gen. Virol. 77 Pt 8 (1996) 1941-1946
17. Filiz S., Dalcik H., Yardimoglu M., Gonca S., and Ceylan S. Localization of neural cell adhesion molecule (N-CAM) immunoreactivity in adult rat tissues. Biotech. Histochem. 77 (2002) 127-135
18. Gilch S., Winklhofer K.F., Groschup M.H., Nunziante M., Lucassen R., Spielhaupter C., Muranyi W., Riesner D., Tatzelt J., and Schatzl H.M. Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J. 20 (2001) 3957-3966
19. Gilch S., Wopfner F., Renner-Muller I., Kremmer E., Bauer C., Wolf E., Brem G., Groschup M.H., and Schatzl H.M. Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J. Biol. Chem. 278 (2003) 18524-18531
20. Giri R.K., Young R., Pitstick R., DeArmond S.J., Prusiner S.B., and Carlson G.A. Prion infection of mouse neurospheres. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3875-3880
21. Glatzel M., Abela E., Maissen M., and Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N. Engl. J. Med. 349 (2003) 1812-1820
22. Greenwood A.D., Horsch M., Stengel A., Vorberg I., Lutzny G., Maas E., Schadler S., Erfle V., Beckers J., Schatzl H., and Leib-Mosch C. Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells. J. Mol. Biol. 349 (2005) 487-500
23. Heikenwalder M., Zeller N., Seeger H., Prinz M., Klohn P.C., Schwarz P., Ruddle N.H., Weissmann C., and Aguzzi A. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307 (2005) 1107-1110
24. Kaiser-Schulz G., Heit A., Quintanilla-Martinez L., Hammerschmidt F., Hess S., Jennen L., Rezaei H., Wagner H., and Schatzl H.M. Polylactide-coglycolide microspheres co-encapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses. J. Immunol. 179 (2007) 2797-2807
25. Krammer C., Suhre M.H., Kremmer E., Diemer C., Hess S., Schatzl H.M., Scheibel T., and Vorberg I. Prion protein/protein interactions: fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells. FASEB J. 22 (2008) 762-773
26. Kretzschmar H.A., Prusiner S.B., Stowring L.E., and DeArmond S.J. Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122 (1986) 1-5
27. Kuwahara C., Kubosaki A., Nishimura T., Nasu Y., Nakamura Y., Saeki K., Matsumoto Y., and Onodera T. Enhanced expression of cellular prion protein gene by insulin or nerve growth factor in immortalized mouse neuronal precursor cell lines. Biochem. Biophys. Res. Commun. 268 (2000) 763-766
28. Lazarini F., Castelnau P., Chermann J.F., Deslys J.P., and Dormont D. Modulation of prion protein gene expression by growth factors in cultured mouse astrocytes and PC-12 cells. Brain Res. Mol. Brain Res. 22 (1994) 268-274
29. Liang J., Pan Y.L., Ning X.X., Sun L.J., Lan M., Hong L., Du J.P., Liu N., Liu C.J., Qiao T.D., and Fan D.M. Overexpression of PrPC and its antiapoptosis function in gastric cancer. Tumour Biol. 27 (2006) 84-91
30. Ligios C., Sigurdson C.J., Santucciu C., Carcassola G., Manco G., Basagni M., Maestrale C., Cancedda M.G., Madau L., and Aguzzi A. PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nat. Med. 11 (2005) 1137-1138
31. Moudjou M., Frobert Y., Grassi J., and La Bonnardiere C. Cellular prion protein status in sheep: tissue-specific biochemical signatures. J. Gen. Virol. 82 (2001) 2017-2024
32. Mulder H., Myrsen-Axcrona U., Gebre-Medhin S., Ekblad E., and Sundler F. Expression of non-classical islet hormone-like peptides during the embryonic development of the pancreas. Microsc. Res. Tech. 43 (1998) 313-321
33. Nixon R.R. Prion-associated increases in Src-family kinases. J. Biol. Chem. 280 (2005) 2455-2462
34. Nunziante M., Gilch S., and Schatzl H.M. Prion diseases: from molecular biology to intervention strategies. ChemBioChem 4 (2003) 1268-1284
35. Ostlund P., Lindegren H., Pettersson C., and Bedecs K. Up-regulation of functionally impaired insulin-like growth factor-1 receptor in scrapie-infected neuroblastoma cells. J. Biol. Chem. 276 (2001) 36110-36115
36. Perrier V., Solassol J., Crozet C., Frobert Y., Mourton-Gilles C., Grassi J., and Lehmann S. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J. Neurochem. 89 (2004) 454-463
37. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
38. Prusiner S.B., Scott M., Foster D., Pan K.M., Groth D., Mirenda C., Torchia M., Yang S.L., Serban D., and Carlson G.A. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63 (1990) 673-686
39. Ramasamy I., Law M., Collins S., and Brooke F. Organ distribution of prion proteins in variant Creutzfeldt-Jakob disease. Lancet, Infect. Dis. 3 (2003) 214-222
40. Rubenstein R., Carp R.I., and Callahan S.M. In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J. Gen. Virol. 65 Pt 12 (1984) 2191-2198
41. Rubenstein R., Scalici C.L., Papini M.C., Callahan S.M., and Carp R.I. Further characterization of scrapie replication in PC12 cells. J. Gen. Virol. 71 Pt 4 (1990) 825-831
42. Rubenstein R., Deng H., Race R., Ju W., Scalici C., Papini M., Rubenstein A., Kascsak R., and Carp R. Scrapie strain infection in vitro induces changes in neuronal cells. Mol. Neurobiol. 8 (1994) 129-138
43. Schatzl H.M., Laszlo L., Holtzman D.M., Tatzelt J., DeArmond S.J., Weiner R.I., Mobley W.C., and Prusiner S.B. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J. Virol. 71 (1997) 8821-8831
44. Simoneau S., Rezaei H., Sales N., Kaiser-Schulz G., Lefebvre-Roque M., Vidal C., Fournier J.G., Comte J., Wopfner F., Grosclaude J., Schatzl H., and Lasmezas C.I. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog. 3 (2007) e125
45. Simons K., and Ehehalt R. Cholesterol, lipid rafts, and disease. J. Clin. Invest. 110 (2002) 597-603
46. Spielhaupter C., and Schatzl H.M. PrPC directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276 (2001) 44604-44612
47. Strom A., Wang G.S., Reimer R., Finegood D.T., and Scott F.W. Pronounced cytosolic aggregation of cellular prion protein in pancreatic beta-cells in response to hyperglycemia. Lab. Invest. 87 (2007) 139-149
48. Taraboulos A., Scott M., Semenov A., Avrahami D., Laszlo L., and Prusiner S.B. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129 (1995) 121-132
49. Tatzelt J., and Schatzl H.M. Molecular basis of cerebral neurodegeneration in prion diseases. FEBS J. 274 (2007) 606-611
50. Tilly G., Chapuis J., Vilette D., Laude H., and Vilotte J.L. Efficient and specific down-regulation of prion protein expression by RNAi. Biochem. Biophys. Res. Commun. 305 (2003) 548-551
51. Vetrugno V., Cardinale A., Filesi I., Mattei S., Sy M.S., Pocchiari M., and Biocca S. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity. Biochem. Biophys. Res. Commun. 338 (2005) 1791-1797
52. Vilette D., Andreoletti O., Archer F., Madelaine M.F., Vilotte J.L., Lehmann S., and Laude H. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4055-4059
53. Vorberg I., Raines A., and Priola S.A. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. J. Biol. Chem. 279 (2004) 29218-29225
54. Vorberg I., Raines A., Story B., and Priola S.A. Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J. Infect. Dis. 189 (2004) 431-439
55. Wadsworth J.D., Joiner S., Hill A.F., Campbell T.A., Desbruslais M., Luthert P.J., and Collinge J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358 (2001) 171-180
56. Wadsworth J.D., Hill A.F., Beck J.A., and Collinge J. Molecular and clinical classification of human prion disease. Br. Med. Bull. 66 (2003) 241-254
57. Watts J.C., Balachandran A., and Westaway D. The expanding universe of prion diseases. PLoS Pathog. 2 (2006) e26
58. Weise J., Sandau R., Schwarting S., Crome O., Wrede A., Schulz-Schaeffer W., Zerr I., and Bahr M. Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 37 (2006) 1296-1300
59. Weissmann C. Molecular biology of transmissible spongiform encephalopathies. Prog. Brain Res. 105 (1995) 15-22
60. Wille H., Michelitsch M.D., Guenebaut V., Supattapone S., Serban A., Cohen F.E., Agard D.A., and Prusiner S.B. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3563-3568
61. Wong K., Qiu Y., Hyun W., Nixon R., VanCleff J., Sanchez-Salazar J., Prusiner S.B., and DeArmond S.J. Decreased receptor-mediated calcium response in prion-infected cells correlates with decreased membrane fluidity and IP3 release. Neurology 47 (1996) 741-750
62. Xiang W., Windl O., Wunsch G., Dugas M., Kohlmann A., Dierkes N., Westner I.M., and Kretzschmar H.A. Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J. Virol. 78 (2004) 11051-11060
63. Xiang W., Hummel M., Mitteregger G., Pace C., Windl O., Mansmann U., and Kretzschmar H.A. Transcriptome analysis reveals altered cholesterol metabolism during the neurodegeneration in mouse scrapie model. J. Neurochem. 102 (2007) 834-847
64. Zawlik I., Witusik M., Hulas-Bigoszewska K., Piaskowski S., Szybka M., Golanska E., Liberski P.P., and Rieske P. Regulation of PrPC expression: nerve growth factor (NGF) activates the prion gene promoter through the MEK1 pathway in PC12 cells. Neurosci. Lett. 400 (2006) 58-62